Peptide loading complex

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

peptide loading complex; PLC

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Name for a complex consisting of a heterodimeric transporter protein, of the peptide of endogenous, viral or microbial origin to be processed, of MHC-I molecules as well as of 4 chaperones (calnexin, Erp57, calreticulin, tapasin). The peptide loading complex plays a central role in the endogenous antigen/allergen presentation (endogenous antigen-MHC class I presentation pathway).

General informationThis section has been translated automatically.

In the cytosol and in the nucleus of every cell, the degradation of cytosolic proteins recognized as foreign is mediated in a complex process via the so-called proteasome complex(also called proteasome), a macromolecular "shredder". This produces a large number of protein fragments, peptides, which are brought into the endoplasmic reticulum (ER) via a membrane so that they can be presented on the cell surface. This important transport and subsequent loading of the MHC-I molecule is carried out by a membrane-bound macromolecular machine, the peptide loading complex (PLC).

Via the chaperones, the PLC enables optimal folding and stabilization of the MHC heterodimer and its loading with the folded high-affinity peptides. After binding of the peptide to the MHC-I complex, the chaperones are released: the newly formed peptide-MHC-I complex leaves the endoplasmic reticulum in vesicular structures. These cross the Golgi apparatus and fuse with the cell membrane. Thus the peptide-MHC-I complex can be presented on the cell surface and can be recognized by the specific TCR (receptor) of CD8-positive lymphocytes.

In the MHC-I presentation pathway, antigen processing involves cytosolic proteins of endogenous, viral or microbial origin. The process of presentation via the MHC-I molecule provides the basis for the differentiation of endogenous fragments from foreign bodies, pathogens and tumour cells.

Authors

Last updated on: 29.10.2020